Nie, J., Zhu, H., Gao, Z., & Wang, L. (2026). Hypoxia‐preconditioned MiotEVs from bone marrow mesenchymal stem cells inhibit myocardial infarction‐induced cardiac fibrosis. Bioengineering & Translational Medicine, 11(1), 1. https://doi.org/10.1002/btm2.70046
Chicago Style (17th ed.) CitationNie, Jungang, Hongwen Zhu, Zhiming Gao, and Liang Wang. "Hypoxia‐preconditioned MiotEVs from Bone Marrow Mesenchymal Stem Cells Inhibit Myocardial Infarction‐induced Cardiac Fibrosis." Bioengineering & Translational Medicine 11, no. 1 (2026): 1. https://doi.org/10.1002/btm2.70046.
MLA (9th ed.) CitationNie, Jungang, et al. "Hypoxia‐preconditioned MiotEVs from Bone Marrow Mesenchymal Stem Cells Inhibit Myocardial Infarction‐induced Cardiac Fibrosis." Bioengineering & Translational Medicine, vol. 11, no. 1, 2026, p. 1, https://doi.org/10.1002/btm2.70046.